Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

Market Cap	21.78B +9.1%
Revenue (ttm)	2.34B -22.1%
Net Income	2.57B +79.6%
EPS	2.18 +77.8%
Shares Out	1.17B
PE Ratio	8.53
Forward PE	n/a
Dividend	0.50 (2.68%)
Ex-Dividend Date	Oct 22, 2025

Volume	9,875,038
Average Volume	12,223,732
Open	18.67
Previous Close	18.66
Day's Range	18.47 - 18.73
52-Week Range	14.85 - 22.08
Beta	0.62
RSI	42.64
Earnings Date	Apr 18, 2026

About SHE:000623

Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 5,454
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000623

Financial Performance

In 2024, SHE:000623's revenue was 2.61 billion, a decrease of -24.31% compared to the previous year's 3.45 billion. Earnings were 1.55 billion, an increase of 6.27%.